222 related articles for article (PubMed ID: 20668223)
1. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.
Rausch MP; Irvine KR; Antony PA; Restifo NP; Cresswell P; Hastings KT
J Immunol; 2010 Sep; 185(5):2828-35. PubMed ID: 20668223
[TBL] [Abstract][Full Text] [Related]
2. GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1.
Rausch MP; Hastings KT
J Invest Dermatol; 2012 Jan; 132(1):154-62. PubMed ID: 21833020
[TBL] [Abstract][Full Text] [Related]
3. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
Rausch MP; Hastings KT
PLoS One; 2015; 10(4):e0123332. PubMed ID: 25875653
[TBL] [Abstract][Full Text] [Related]
4. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT
J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095
[TBL] [Abstract][Full Text] [Related]
5. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing.
Hastings KT; Lackman RL; Cresswell P
J Immunol; 2006 Dec; 177(12):8569-77. PubMed ID: 17142755
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
[TBL] [Abstract][Full Text] [Related]
7. Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire.
Bogunovic B; Srinivasan P; Ueda Y; Tomita Y; Maric M
PLoS One; 2010 May; 5(5):e10599. PubMed ID: 20485683
[TBL] [Abstract][Full Text] [Related]
8. High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.
Buetow KH; Meador LR; Menon H; Lu YK; Brill J; Cui H; Roe DJ; DiCaudo DJ; Hastings KT
J Immunol; 2019 Nov; 203(10):2577-2587. PubMed ID: 31591149
[TBL] [Abstract][Full Text] [Related]
9. MHC class II-restricted presentation of the major house dust mite allergen Der p 1 Is GILT-dependent: implications for allergic asthma.
West LC; Grotzke JE; Cresswell P
PLoS One; 2013; 8(1):e51343. PubMed ID: 23326313
[TBL] [Abstract][Full Text] [Related]
10. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A
Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune etiology of generalized vitiligo.
Le Poole IC; Luiten RM
Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.
Gregg RK; Nichols L; Chen Y; Lu B; Engelhard VH
J Immunol; 2010 Feb; 184(4):1909-17. PubMed ID: 20083666
[TBL] [Abstract][Full Text] [Related]
13. A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice.
Bergman CM; Marta CB; Maric M; Pfeiffer SE; Cresswell P; Ruddle NH
J Immunol; 2012 Jun; 188(12):6001-9. PubMed ID: 22586035
[TBL] [Abstract][Full Text] [Related]
14. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
Robbins PF; El-Gamil M; Li YF; Zeng G; Dudley M; Rosenberg SA
J Immunol; 2002 Nov; 169(10):6036-47. PubMed ID: 12421991
[TBL] [Abstract][Full Text] [Related]
15. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein.
Hara I; Takechi Y; Houghton AN
J Exp Med; 1995 Nov; 182(5):1609-14. PubMed ID: 7595233
[TBL] [Abstract][Full Text] [Related]
16. GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity.
Phipps-Yonas H; Semik V; Hastings KT
Eur J Immunol; 2013 Jan; 43(1):65-74. PubMed ID: 23012103
[TBL] [Abstract][Full Text] [Related]
17. Defective antigen processing in GILT-free mice.
Maric M; Arunachalam B; Phan UT; Dong C; Garrett WS; Cannon KS; Alfonso C; Karlsson L; Flavell RA; Cresswell P
Science; 2001 Nov; 294(5545):1361-5. PubMed ID: 11701933
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.
Jensen SM; Twitty CG; Maston LD; Antony PA; Lim M; Hu HM; Petrausch U; Restifo NP; Fox BA
J Immunol; 2012 Jul; 189(2):767-76. PubMed ID: 22723522
[TBL] [Abstract][Full Text] [Related]
19. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.
Lambe T; Leung JC; Bouriez-Jones T; Silver K; Makinen K; Crockford TL; Ferry H; Forrester JV; Cornall RJ
J Immunol; 2006 Sep; 177(5):3055-62. PubMed ID: 16920942
[TBL] [Abstract][Full Text] [Related]
20. Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase.
Hastings KT; Cresswell P
Antioxid Redox Signal; 2011 Aug; 15(3):657-68. PubMed ID: 21506690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
